Cargando…

Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19

The outbreak of coronavirus disease 2019 (COVID-19) has led to the emergence of global health care. In this study, we aimed to explore the association between drug treatments and the incidence of drug-induced liver injury (DILI) in hospitalized patients with COVID-19. A retrospective study was condu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Suyu, Yang, Qingqing, Wang, Xuanxuan, Hu, Wen, Lu, Yun, Yang, Kun, Jiang, Qiaoli, Li, Wenjing, Song, Haibo, Sun, Feng, Cheng, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978013/ https://www.ncbi.nlm.nih.gov/pubmed/35387350 http://dx.doi.org/10.3389/fphar.2022.799338

Ejemplares similares

Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross‐Sectional Study
por: Hu, Wen, et al.
Publicado: (2022)

Drug-induced liver injury associated with dacomitinib: A case report
por: Wang, Xuanxuan, et al.
Publicado: (2022)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Aripiprazole-induced liver injury: a spontaneous reporting database study
por: Gao, Yunjuan, et al.
Publicado: (2023)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Correlation between serum cytokines and clinicopathological features in patients with drug-induced liver injury
por: Zhang, Yu, et al.
Publicado: (2022)

Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database
por: Zhou, Zhi-Xuan, et al.
Publicado: (2022)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
por: Song, Shuailing, et al.
Publicado: (2023)

Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
por: Fu, Siyu, et al.
Publicado: (2020)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

Healthcare professionals’ knowledge, attitude and practice towards National Centralized Drug Procurement policy in central China: A cross-sectional study
por: Huang, Anqi, et al.
Publicado: (2022)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

The Study on the Mechanism of Hugan Tablets in Treating Drug-Induced Liver Injury Induced by Atorvastatin
por: Lv, Shujing, et al.
Publicado: (2021)

Beware of the Potential Risks for Polygoni Multiflori Caulis-Induced Liver Injury
por: Kong, Wei-Song, et al.
Publicado: (2022)

Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients
por: Chen, Qin, et al.
Publicado: (2022)

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
por: Zhou, Yitian, et al.
Publicado: (2019)

N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study
por: Cheng, Fang, et al.
Publicado: (2023)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022)

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
por: Woodhead, Jeffrey L., et al.
Publicado: (2014)

Effect of Puerarin Regulated mTOR Signaling Pathway in Experimental Liver Injury
por: Zhou, Bu-Gao, et al.
Publicado: (2018)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
por: Liu, Wenhui, et al.
Publicado: (2021)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review
por: Björnsson, Einar S., et al.
Publicado: (2022)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
por: Huang, Jingjing, et al.
Publicado: (2022)

Hepatoprotective Potential of Pomegranate in Curbing the Incidence of Acute Liver Injury by Alleviating Oxidative Stress and Inflammatory Response
por: Ali, Hamid, et al.
Publicado: (2021)

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury
por: Yang, Ruiyuan, et al.
Publicado: (2022)

Ferrostatin-1 Ameliorates Liver Dysfunction via Reducing Iron in Thioacetamide-induced Acute Liver Injury in Mice
por: Jiang, Hui, et al.
Publicado: (2022)

Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review
por: Benić, Mirjana Stanić, et al.
Publicado: (2022)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
por: Xiong, Yu-Ting, et al.
Publicado: (2023)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
por: Robles-Díaz, Mercedes, et al.
Publicado: (2022)

Study on the liver Drug’s dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction
por: Wang, Qun, et al.
Publicado: (2023)

Psoralen Induced Liver Injury by Attenuating Liver Regenerative Capability
por: Zhou, Wang, et al.
Publicado: (2018)

Fisetin Prevents Acetaminophen-Induced Liver Injury by Promoting Autophagy
por: Zhang, Jiaqi, et al.
Publicado: (2020)

Drugs and the liver
por: Vaja, Rakesh, et al.
Publicado: (2020)

Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method
por: Ye, Ling, et al.
Publicado: (2021)

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
por: Danan, Gaby, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5etl0r8ij5p11bgvbh6bp9j7ql